| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |